Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entrada Therapeutics (TRDA) Current Taxes (2023 - 2025)

Entrada Therapeutics has reported Current Taxes over the past 3 years, most recently at $620000.0 for Q3 2025.

  • Quarterly results put Current Taxes at $620000.0 for Q3 2025, down 72.46% from a year ago — trailing twelve months through Sep 2025 was $620000.0 (down 72.46% YoY), and the annual figure for FY2024 was $667000.0, down 83.42%.
  • Current Taxes for Q3 2025 was $620000.0 at Entrada Therapeutics, down from $802000.0 in the prior quarter.
  • Over the last five years, Current Taxes for TRDA hit a ceiling of $7.4 million in Q2 2023 and a floor of $620000.0 in Q3 2025.
  • Median Current Taxes over the past 3 years was $3.1 million (2023), compared with a mean of $3.2 million.
  • Biggest five-year swings in Current Taxes: plummeted 44.14% in 2024 and later plummeted 86.3% in 2025.
  • Entrada Therapeutics' Current Taxes stood at $4.0 million in 2023, then tumbled by 83.42% to $667000.0 in 2024, then decreased by 7.05% to $620000.0 in 2025.
  • The last three reported values for Current Taxes were $620000.0 (Q3 2025), $802000.0 (Q1 2025), and $667000.0 (Q4 2024) per Business Quant data.